Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Biochemical comparison by sex showed higher 25(OH)D levels in males (33.4 ± 7.0 vs 23.3 ± 7.8 ng/mL; p = 0.033) whereas females tended to have a greater PTH fold increase compared with males (1.46 ± 0.39 vs 1.00 ± 0.38; p = 0.043).
Source: Clinical and biochemical profile of PHPT. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were eligible if the genetic diagnosis of MEN1 was established at ≤21 years of age.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Clinical features of MEN1 in children, adolescents, and young adults: a single-center study
Study design awaiting verification · Frontiers in Endocrinology · 2026
Original publication title
Clinical features of MEN1 in children, adolescents, and young adults: a single-center study
Copyright © 2026 Della Valentina, Pierotti, Pardi, Sardella, Dal Lago, Michelucci, Caligo, Materazzi, Frustaci, Kauffmann, Boggi, Piaggi, Marcocci and Cetani.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Multiple endocrine neoplasia type 1 (MEN1) can present during childhood and adolescence, yet data on the full endocrine and non-endocrine phenotype in young patients remain limited.
Source: BackgroundAbstract: What methods does the paper describe?
We conducted a retrospective single-center study of genetically confirmed MEN1 patients diagnosed at ≤21 years and followed between 2001 and 2024. Clinical features, surveillance findings, treatments, and outcomes were extracted from medical records.
Source: MethodsAbstract: Results
The cohort included 21 patients (52% males), with a median age at genetic diagnosis of 15 years and a median follow-up of 9 years. At first evaluation, 33% were asymptomatic MEN1 pathogenic/likely pathogenic variant carriers. During follow-up, primary hyperparathyroidism (PHPT) developed in 71% (median age 18 years) and was frequently complicated by renal and skeletal involvement (hypercalciuria, silent nephrolithiasis, and reduced bone mass). Parathyroidectomy was performed in 33% of patients with PHPT, with variable surgical approaches. Both postoperative hypoparathyroidism and persistent or recurrent disease were documented.
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) occurred in 48% (median age ~19.5 years), predominantly non-functioning and pancreatic, with surgery in <40% and no metastatic disease. Pituitary adenomas were detected in 52% (mostly non-functioning); one pediatric prolactinoma responded to cabergoline. Adrenal involvement (14%), cutaneous lesions (angiofibromas 33%; lipomas 19%), and thoracic neuroendocrine lesions (19%, all >21 years) broadened the early-life MEN1 phenotype.
Source: ResultsAbstract: Conclusions
In MEN1 patients diagnosed at ≤21 years, early disease expression is common and clinically meaningful. PHPT represents the earliest and most prevalent manifestation and is frequently associated with renal and skeletal morbidity despite sometimes mild biochemical abnormalities. GEP-NETs and pituitary adenomas are also prevalent by late adolescence/young adulthood and are often indolent, suggesting structured, age-adapted multidisciplinary surveillance and early cascade genetic testing in at-risk families.
Source: ConclusionsAuthors’ abstract
Background
Multiple endocrine neoplasia type 1 (MEN1) can present during childhood and adolescence, yet data on the full endocrine and non-endocrine phenotype in young patients remain limited.
Methods
We conducted a retrospective single-center study of genetically confirmed MEN1 patients diagnosed at ≤21 years and followed between 2001 and 2024. Clinical features, surveillance findings, treatments, and outcomes were extracted from medical records.
Results
The cohort included 21 patients (52% males), with a median age at genetic diagnosis of 15 years and a median follow-up of 9 years. At first evaluation, 33% were asymptomatic MEN1 pathogenic/likely pathogenic variant carriers. During follow-up, primary hyperparathyroidism (PHPT) developed in 71% (median age 18 years) and was frequently complicated by renal and skeletal involvement (hypercalciuria, silent nephrolithiasis, and reduced bone mass). Parathyroidectomy was performed in 33% of patients with PHPT, with variable surgical approaches. Both postoperative hypoparathyroidism and persistent or recurrent disease were documented.
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) occurred in 48% (median age ~19.5 years), predominantly non-functioning and pancreatic, with surgery in <40% and no metastatic disease. Pituitary adenomas were detected in 52% (mostly non-functioning); one pediatric prolactinoma responded to cabergoline. Adrenal involvement (14%), cutaneous lesions (angiofibromas 33%; lipomas 19%), and thoracic neuroendocrine lesions (19%, all >21 years) broadened the early-life MEN1 phenotype.
Conclusions
In MEN1 patients diagnosed at ≤21 years, early disease expression is common and clinically meaningful. PHPT represents the earliest and most prevalent manifestation and is frequently associated with renal and skeletal morbidity despite sometimes mild biochemical abnormalities. GEP-NETs and pituitary adenomas are also prevalent by late adolescence/young adulthood and are often indolent, suggesting structured, age-adapted multidisciplinary surveillance and early cascade genetic testing in at-risk families.
Publication and source details
Original title: Clinical features of MEN1 in children, adolescents, and young adults: a single-center study
Simone Della Valentina; Laura Pierotti; Elena Pardi; Chiara Sardella; Anna Dal Lago; Angela Michelucci; Maria Adelaide Caligo; Gabriele Materazzi; Gianluca Frustaci; Emanuele Federico Kauffmann; Ugo Boggi; Paolo Piaggi; Claudio Marcocci; Filomena Cetani
Frontiers in Endocrinology · 2026
* Correspondence: Filomena Cetani, filomena.cetani@unipi.itCopyright © 2026 Della Valentina, Pierotti, Pardi, Sardella, Dal Lago, Michelucci, Caligo, Materazzi, Frustaci, Kauffmann, Boggi, Piaggi, Marcocci and Cetani.2026Della Valentina, Pierotti, Pardi, Sardella, Dal Lago, Michelucci, Caligo, Materazzi, Frustaci, Kauffmann, Boggi, Piaggi, Marcocci and Cetanihttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:54:15.563531+00:00
DOI: 10.3389/fendo.2026.1886831 · PMC13526606